Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, Publications Management

Employer
Regeneron Pharmaceuticals, Inc.
Location
Tarrytown, NY
Start date
Jun 19, 2019

View more

Discipline
Clinical, Clinical Data
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Pharm Country, Best Places to Work

Job Details

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases.

Summary:

This position requires strong scientific and extensive publication management experience. Work with company scientists and other internal stakeholders, study investigators and authors, external pharmaceutical company partners, and medical communication agencies in leading cross-functional publication teams for one or more therapeutic areas for the development of scientific publication plans (covering research manuscripts and conference presentations) and their execution. Demonstrated ability to work with stakeholders in a pharma company setting and manage publication vendors is required. Ability to write manuscripts is a must.

Responsibilities:
  • Lead cross-functional publication teams (together with other pharma partners) to develop, manage and execute the publication plan of one or more therapeutic areas. This involves the development and submission of clinical manuscripts, abstracts, and scientific meeting presentations with company teams, publication vendors, external collaborators, scientists, and medical experts.
  • Understand the science of the assigned therapeutic areas. Guide and oversee publication vendors, contract writers and editors, draft budgets, and travel to scientific conferences as needed.
  • Write manuscripts, abstracts, posters on behalf of authors.

Requirements:
  • At least 6 years in medical communications or publications management, of which 2-3 years must have been spent in independently leading cross-functional publication teams to develop and execute therapeutic area-specific publication plans. Some or all of this experience must be from a pharmaceutical company; additional experience in a medical communication agency is a plus. Experience in medical writing required.
  • Quickly develop a firm scientific understanding of the therapeutic area(s) covered; should possess an understanding of clinical study design, statistics, and pharmaceutical research and development. Familiarity with statistical analysis plans and clinical study reports.
  • Must be able to write manuscripts, abstracts, posters on behalf of authors. Oversee publication vendors, contract writers and editors, drafting publication budgets. Prior use of publication software (e.g., Datavision) a plus.
  • Excellent knowledge of and compliance with Good publication practices, ICMJE guidelines, CONSORT, Sunshine Act
  • Strong project management skills, with demonstrated ability to work on multiple projects efficiently are important. Excellent written and oral communication skills are required. Additionally, exemplary professional interaction with internal stakeholders and external authors is expected.

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert